{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-015586","form_type":"8-K","ticker":"AIFC","cik":"0000862861","company_name":"AI Financial Corp","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.543134+00:00","generated_at":"2026-05-24T02:42:52.051380+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"ALT5 Sigma Q4 fintech revenue $5.4M; 1,000+ customers; appoints COO","bullets":["Q4 fintech revenue $5.42M; full-year fintech revenue (from May 15) $12.53M; adjusted EBITDA ~$1.03M.","Fintech segment full-year gross margin 50.2%; adjusted EBITDA 18.2%; working capital improved $4.5M QoQ.","Customer base exceeded 1,000; cash and equivalents $7.18M as of Dec 28, 2024.","Ron Pitters appointed COO; board approved separation of fintech and biotech (Alyea) into independent entities.","Alyea Therapeutics preparing for standalone listing; key leadership team appointed including Dr. Amol Soin CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-015586","json":"https://secwatch.observer/filing/0001628280-25-015586.json","markdown":"https://secwatch.observer/filing/0001628280-25-015586.md","text":"https://secwatch.observer/filing/0001628280-25-015586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862861/000162828025015586/0001628280-25-015586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862861/000162828025015586/jan-20250328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T02:42:52.051380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}